CAS: 1201902-80-8 - MLN9708

Formula: C₂₀H₂₃BCl₂N₂O₉

Sinonimi:

• 4-Carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic acid
• Ixazomib

1,3,2-Dioxaborinane-4-acetic acid, 4-carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-

CAS: 1201902-80-8

• Formula: C₂₀H₂₃BCl₂N₂O₉
• Purezza: 98%
• Colore e forma: Solid
• Peso molecolare: 517.1216

MLN9708

CAS: 1201902-80-8

MLN2238 inhibits 20S proteasome's β5 site (Ki50=0.93 nM, IC50=3.4 nM), active form of Ixazomib Citrate …

• Formula: C₂₀H₂₃BCl₂N₂O₉
• Purezza: 98.24% - ≥95%
• Colore e forma: Solid
• Peso molecolare: 517.12

Ixazomib Citrate

CAS: 1201902-80-8

• Formula: C₂₀H₂₃BCl₂N₂O₉
• Colore e forma: Neat
• Peso molecolare: 517.12

MLN-9708

CAS: 1201902-80-8

Applications MLN-9708 is a novel proteasome inhibitor. References Kupperman, Erik., et al.: Cancer Res., 70, …

• Formula: C₂₀H₂₃BCl₂N₂O₉
• Colore e forma: Neat
• Peso molecolare: 517.12

Ixazomib Citrate (MLN9708)

CAS: 1201902-80-8

Ixazomib Citrate (MLN9708) is a proteasome inhibitor that belongs to the class of investigational agents. …

• Formula: C₂₀H₂₃BCl₂N₂O₉
• Purezza: Min. 95%
• Peso molecolare: 517.12 g/mol